Recent Updates
Recently added Catalysts
KMTS Positive Sentiment Score: 85/100

Kestra Medical Technologies, Ltd. Appoints Al Ford as Chief Commercial Officer

Key Takeaway: Kestra Medical Technologies announced the appointment of Al Ford as Chief Commercial Officer (CCO). Ford, who brings 20 years of experience in MedTech, will lead the company's sales strategies and operations. His expertise, particularly in defibrillation technologies, is anticipated to enhance the commercial team. Kestra aims to improve patient outcomes in cardiovascular disease through its innovative device portfolio.

Market Sentiment Analysis

POSITIVE FACTORS

  • Appointment of Al Ford as CCO demonstrates strategic leadership.
  • Ford's extensive experience in MedTech is expected to benefit Kestra.
  • The focus on transforming patient outcomes in cardiovascular disease is promising.

Full Press Release Details

KIRKLAND, Wash., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies Ltd. (“Kestra”), a wearable medical device and digital healthcare company, announced today that Al Ford is joining the company as Chief Commercial Officer (CCO). Mr. Ford will be responsible for advancing sales strategies and leading the Kestra commercial team.
“We are pleased to welcome Al to the team,” said Brian Webster, President and Chief Executive Officer at Kestra. “With significant experience managing strategic sales and commercial operations, he brings valuable knowledge, perspective, and leadership to our organization. Al also has deep experience in the underlying defibrillation technologies that are central to the ASSURE® system. We are confident that he will be an impactful addition as we continue to drive adoption of our lifesaving system.”
Mr. Ford brings 20 years of experience in MedTech organizations to his new role at Kestra. Most recently, he served as Chief Commercial Officer at Axonics where he led the development and execution of their commercialization strategy. Prior to that, he was Chief Commercial Officer at Cardiac Science Corporation.
“I am honored to join Kestra in a commercial leadership role that aligns seamlessly with my experience,” said Mr. Ford. "The innovative Cardiac Recovery System® portfolio, and its ability to positively impact the lives of a meaningfully underserved patient population, were significant factors in my decision to join Kestra. I look forward to working with the team to execute on our commitment to patients and their prescribers.”
Kestra Medical Technologies, Ltd. is a commercial-stage wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using diagnostic monitoring and therapeutic technologies that are intuitive, intelligent, and connected. Kestra was founded in 2014 by leaders from the external (AED) and implantable (ICD) defibrillation industries. For more information, visit www.kestramedical.com.
Marissa Bych or Webb Campbell
Kestra Medical Technologies, Inc.

Frequently Asked Questions

Who is the new Chief Commercial Officer at Kestra?

Al Ford has been appointed as the Chief Commercial Officer at Kestra.

What will Al Ford do at Kestra Medical Technologies?

He will lead sales strategies and oversee the commercial team at Kestra.

What experience does Al Ford bring to Kestra?

He has 20 years in MedTech, previously serving as CCO at Axonics and Cardiac Science.

Why did Al Ford join Kestra?

He was attracted to the Cardiac Recovery System® and its impact on underserved patients.

What is Kestra Medical Technologies focused on?

Kestra specializes in wearable devices and digital health solutions for cardiovascular care.

Last updated: Feb 18, 2025